Extendicare Stock Today
| EXE Stock | CAD 7.52 0.05 0.66% |
Performance3 of 100
| Odds Of DistressLess than 5
|
Extendicare is selling at 7.52 as of the 8th of June 2024; that is -0.66% down since the beginning of the trading day. The stock's open price was 7.57. Extendicare has under 5 % chance of experiencing financial distress over the next 2 years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Extendicare are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of May 2024 and ending today, the 8th of June 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Extendicare Inc. provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. EXTENDICARE INC operates under Medical Care Facilities classification in Canada and is traded on Toronto Stock Exchange. The company has 83.38 M outstanding shares of which 1.52 M shares are currently shorted by private and institutional investors with about 15.84 days to cover all short positions. More on Extendicare
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Extendicare Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Extendicare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Extendicare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | MBA MD | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | ||||
Extendicare's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Extendicare's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Extendicare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Extendicare's financial leverage. It provides some insight into what part of Extendicare's total assets is financed by creditors.
| |||||
Extendicare (EXE) is traded on Toronto Exchange in Canada and employs 26 people. Extendicare is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 631.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Extendicare's market, we take the total number of its shares issued and multiply it by Extendicare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Extendicare operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 83.38 M outstanding shares of which 1.52 M shares are currently shorted by private and institutional investors with about 15.84 days to cover all short positions.
Extendicare has accumulated about 167.28 M in cash with 23.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Check Extendicare Probability Of Bankruptcy
Ownership AllocationExtendicare retains a total of 83.38 Million outstanding shares. Extendicare shows 13.91 percent of its outstanding shares held by insiders and 19.77 percent owned by other corporate entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Extendicare Ownership Details
Extendicare Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Extendicare market risk premium is the additional return an investor will receive from holding Extendicare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Extendicare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Extendicare's alpha and beta are two of the key measurements used to evaluate Extendicare's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.24 | |||
| Semi Deviation | 1.69 | |||
| Standard Deviation | 1.96 | |||
| Variance | 3.84 |
Extendicare Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Extendicare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Extendicare Corporate Directors
| Samir Manji | Independent Director | Profile | |
| Sandra Hanington | Independent Director | Profile | |
| Alan Hibben | Independent Director | Profile | |
| Donna Kingelin | Independent Director | Profile |
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.